# Study of Sublingual Versus Oral Misoprostol Administration Following Mifepristone 200 mg for Abortion up to 63 Days Gestation

> **NCT00286208** · NA · COMPLETED · sponsor: **Gynuity Health Projects** · enrollment: 1443 (actual)

## Conditions studied

- Induced Abortion

## Interventions

- **DRUG:** Mifepristone, misoprostol

## Key facts

- **NCT ID:** NCT00286208
- **Lead sponsor:** Gynuity Health Projects
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 1443 (ACTUAL)
- **Last updated:** 2014-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00286208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00286208, "Study of Sublingual Versus Oral Misoprostol Administration Following Mifepristone 200 mg for Abortion up to 63 Days Gestation". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00286208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*